Abstract:Objective To evaluate the safety and efficacy of transcatheter closure of post-surgery residual ventricular septal defect( VSD)and its mid-to long-term follow-up results. Methods The clinical data of patients with post-surgery residual VSD who underwent an attempt of percutaneous device closure from September 2002 to December 2013 in Childrenˊs Hospital of Fudan University were summarized. Results 21 patients( 11 males and 10 females ) with post-surgery residual VSD underwent an attempt of percutaneous device closure in our center. The mean age was 8. 8 years(2. 7-21 years)and the mean weight was 26. 3 kg(10. 5-53. 5 kg). Among these 21 patients,their previous surgery procedures were VSD repair in 13 cases,repair of tetralogy of Fallot( TOF)in 5 cases,repair of double outlet right ventricle( DORV)in 2 cases,and repair of complete transposition of great arteries( TGA)with VSD in 1 case. In addition,1 patient of post-TOF repair was associated with frequently premature ventricular contraction and ventricular tachycardia,2 patients of post VSD repair were associated with recoarctation of the aorta. The duration between previous surgery and transcathter device closure was 11-80 months. The mean diameter of VSDs in right ventricle( RV) side was 3. 73 mm(1. 6-6. 3 mm)by angiogram. There were multiple shunts in RV side in 4 patients,and one patient was left ventricle to right atrium shunt. The Qp/Qs ratio was 1. 53 ± 0. 23,and there was no pulmonary hypertension more than moderate. Amplatzer devices were successfully deployed in all cases except for 1 failure case due to a repeat complete block during the arterial-venous loop establishing,and 2 devices were used in 1 patient. The median device size was 6. 5 mm(4 -12 mm). A radio-frequency ablation and 2 balloon dilatations were successfully finished for the associated defects in the same procedure. There was no procedure-related adverse events. Mild residual shunt was showed by angiogram and transthoracic echocardiography( TTE ) immediate after closure in 3 patients. Three patients with moderate to severe tricuspid regurgitation before device closure improved significantly after closure. All patients were doing well clinically in a mean 22. 2 months(1 - 79 months)follow up. Minor arrhythmia was observed in 2 patients in the first year follow-up ECG including incomplete right bundle branch and first-degree atrioventricular block,and remained the same in another 6 months to 1 year follow-up. All 3 residual shunts disappeared in the follow-up echocardiography except for a 3. 4 mm residual shunt still existed in 1 patient with normal heart size and function. No new onset tricuspid or aortic regurgitation was showed. There was no device malposition or embolization,or thrombosis formation. Conclusion Transcatheter closure of post-surgery residual ventricular septal defect is safe,effective and less trauma. The mid-to long-term follow-up results of these cases are promising.

Midterm follow-up results of implantation of a fully biodegradable ventricular septal defect occluder

Doubly Committed Ventricular Septal Defect Closure Using Eccentric Occluder Via Ultraminimal Incision

Safety, effectiveness, and complications of the first-in-human minimally invasive transthoracic ventricular septal defect closure using a bioabsorbable occluder: a cohort study with 12-month follow-up

A Study on Eccentric Occluder Via Ultra Minimal Incision of Doubly Committed Subarterial Ventricular Septal Defects

The 3-year follow-up of a fully biodegradable implantable device closure for perimembranous ventricular septal defects in children using echocardiography

Development and Preclinical Evaluation of A Biodegradable Ventricular Septal Defect Occluder

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: a multicenter randomized controlled trial

Transcatheter closure of multi-hole perimembranous VSD with aneurysm: 3-year follow-up study

Transcatheter closure of ventricular septal defects using the new ventricular septal defects occluder

The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

A fully biodegradable polydioxanone occluder for ventricle septal defect closure

2D/3D echocardiography evaluation of efficacy of transcatheter closure ventricular septal defects with double-umbrella nitinol prosthesis

A Novel Biodegradable Occluder for the Closure of Ventricular Septal Defects: Immediate and Medium-Term Results in a Canine Model

Outcome of Transcatheter Closure of Perimembranous Ventricular Septal Defect with Modified Double-Disk Occluder Device

Color echocardiographic evaluation of transcatheter closure of ventricular septal defects using home-made nitinol asymmetric two-disk device

Appraisal of efficacy and safety of ventricular septal defects device occlusion

Finite Element Modeling and Analysis of Ventricular Septal Defect Occluders

Transcatheter Closure Of Perimembranous Ventricular Septal Defect Using A Modified Double-Disk Occluder

Percutaneous Closure of Postoperative Ventricular Septal Residual Left-to-right Shunt with the China-made Device

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients